CP and alkaline phosphatase measurement: The number of patients in which these specific defects in CP (4.6% of all time points) and or AP (11.2% of all time points) do not coincide is suggestive for the presence of some as yet unknown factors, which have a selective deleterious impact on these complement pathways.